NXS 5.00% 21.0¢ next science limited

systematic sell down, page-19

  1. 938 Posts.
    lightbulb Created with Sketch. 157
    Guess-timates on cash flow & Crux value:

    Value of Crux deal $637m aprox (using $75m for 2% of crux as a guide)
    Cash end Q3 $36m
    Recoverable long term lead items? guess $30m
    Est Cash flow Longtom Q4 $13m (if same as Q3)
    -----------
    $716m
    -----------
    Debt end Q3 $234m
    Sedco liability? $30m
    Longtom costs & repayments Q4 $27m
    -----------
    $425m
    -----------
    shares 1326m
    -----------
    Rough value/share cash + crux - debts 425/1326 = 0.32

    Add in speculative estimates for future earnings from Longtom & Prelude?
    Add in speculative estimate for Echuca.

    Undervalued at .11 I think even in worst case scenario. Downward push on price due to big sellers eg M&G. Seems like there must be a different reason for the big sales than just estimated value of the shares in the company.

    With M&G selling lots this is convincing others to sell as well. How much do M&G want to get rid of? If it's all of them it will be a long time before sp goes up again.

    Credit suisse seem to be picking quite a lot of them up!

    Once everything settles down maybe the sp will get back to .30+?
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.010(5.00%)
Mkt cap ! $61.35M
Open High Low Value Volume
20.5¢ 21.0¢ 19.0¢ $31.60K 161.1K

Buyers (Bids)

No. Vol. Price($)
1 7800 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 4944 2
View Market Depth
Last trade - 14.52pm 30/08/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.